The Biden administration warns that other Covid-19 boosters will not be readily available to the public without congressional funding
The Biden administration warns that other Covid-19 boosters will not be readily available to the public without congressional funding

The Biden administration warns that other Covid-19 boosters will not be readily available to the public without congressional funding

However, there will be enough supply for seniors and immunocompromised Americans.

“We have a sufficient current stock of vaccines, both in states and pharmacies and other access points around the country and in our central stock for fourth doses, if they are called up this spring for our most vulnerable, including seniors,” Covid in The White House. -19 response coordinator Jeff Zients said in response to a question from CNN during Wednesday’s briefing.

“Where we do not have sufficient doses is later in the year, if science dictates that all Americans should get a booster, or if there is a need for a new formulation of the vaccine, a variant-specific vaccine, for example, then we will not have sufficient supply. , “Zients added, calling the situation” completely unacceptable. “

Dr. Anthony Fauci, President Joe Biden’s chief medical adviser, suggested that other boosters could be approved by the U.S. Food and Drug Administration to the general public “toward early fall” or “late summer,” though he said another booster could approved for a smaller subgroup, “perhaps older” Americans, in the coming weeks.

Congress is still in a stalemate over what the White House says there is an urgent need for additional funding for the Covid-19 response. In recent weeks, the administration has been actively push criticism back from some Republican lawmakers who are reluctant to spend more money on coronavirus response when money from last year’s Covid Aid proposal is still available.
93 percent of the remaining money from the U.S. rescue plan adopted last year has been committed or distributed to specific grant recipients or groups, including states and locations, according to a document sent by the Biden administration to lawmakers and obtained by CNN last week.

Zients said there is still adequate supply “in the short term” for Americans who need their first dose, second dose or first booster.

Other top public health officials issued similar warnings as the administration continued to advocate for funding.

Fauci warned that the United States “will not be able to continue to make these purchases” of monoclonal antibody treatments without continued funding.

Dr. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, continued to call funding “critical.”

“If cases arise from the Omicron variant or any other variant, we have the tools – vaccines, boosters, tests and therapies to prepare – but continue to invest in these tools so that they are readily available when we need them. those are still critical, “she said. “From a public health point of view, it is crucial that we continue to give people the tools to keep them, their families and their communities safe.”

Zients also warned that “failure to invest now will leave us with inadequate testing capacity and supply,” calling the consequences of congressional inaction “serious” and “immediate.”

Some of the immediate consequences that have already taken place, he said, include the “phasing out” of funding to support uninsured Americans, as well as “fewer life-saving monoclonal antibody treatments being sent to states” and “fewer treatments available to immunocompromised people.”

Leave a Reply

Your email address will not be published.